Figure 7
Figure 7. Survival and GVHD scores of B6D2 mice receiving WT or CCR7−/− Treg cells before WT Tn cell dosing. (A-B) B6D2 recipients were lethally irradiated on day −1 and then administered 3 × 106 TCD BM cells from WT B6 donors with or without 1 × 106 column-purified CD4+CD25+ Treg cells from WT B6 or CCR7−/− B6 mice on day 0. A total of 4 × 106 CD25-depleted Tn cells from WT B6 donors were then administered on day +2.23 n = 4 BM, 7 BM/Tn, 9 BM/Tn/WT Treg, 9BM/Tn/CCR7−/− Treg. (B) *P = .094 for comparison of GVHD scores between WT Treg and CCR7−/− Treg groups on day +70. Error bars indicate SEM.

Survival and GVHD scores of B6D2 mice receiving WT or CCR7−/− Treg cells before WT Tn cell dosing. (A-B) B6D2 recipients were lethally irradiated on day −1 and then administered 3 × 106 TCD BM cells from WT B6 donors with or without 1 × 106 column-purified CD4+CD25+ Treg cells from WT B6 or CCR7−/− B6 mice on day 0. A total of 4 × 106 CD25-depleted Tn cells from WT B6 donors were then administered on day +2.23  n = 4 BM, 7 BM/Tn, 9 BM/Tn/WT Treg, 9BM/Tn/CCR7−/− Treg. (B) *P = .094 for comparison of GVHD scores between WT Treg and CCR7−/− Treg groups on day +70. Error bars indicate SEM.

Close Modal

or Create an Account

Close Modal
Close Modal